Multivalent and multispecific 41BB-binding proteins
US12187804B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2022 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Dec 16, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates generally to molecules that specifically engage 41BB, a member of the TNF receptor superfamily (TNFRSF). More specifically, this invention relates to multivalent and multispecific molecules that bind at least 41BB.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.